Low-power photodynamic therapy induces survival signaling in perihilar cholangiocarcinoma cells

Autor: Thomas M. van Gulik, Rowan F. van Golen, Esther Nieuwenhuis, Mans Broekgaarden, Ruud Weijer, Esther B. Bulle, Michal Heger, Perry D. Moerland, Aldo Jongejan, Antoine H. C. van Kampen
Přispěvatelé: Graduate School, Other departments, Epidemiology and Data Science, AII - Amsterdam institute for Infection and Immunity, APH - Amsterdam Public Health, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Surgery, CCA -Cancer Center Amsterdam, 02 Surgical specialisms
Rok vydání: 2015
Předmět:
Male
Cancer Research
Pathology
medicine.medical_specialty
Indoles
Cell Survival
medicine.medical_treatment
Drug delivery system
Photodynamic therapy
Context (language use)
Isoindoles
Therapeutic recalcitrance
chemistry.chemical_compound
Mice
Immune system
Downregulation and upregulation
In vivo
Genetics
Organometallic Compounds
Medicine
Animals
Humans
Photosensitizer
Propidium iodide
Photosensitizing Agents
business.industry
Metallated phthalocyanines
Gene Expression Profiling
Hypoxia-Inducible Factor 1
alpha Subunit

In vitro
Up-Regulation
Gene Expression Regulation
Neoplastic

Tumor targeting
Oncology
chemistry
Bile Duct Neoplasms
Photochemotherapy
Zinc Compounds
Liposomes
Cancer research
Non-resectable perihilar cholangiocarcinoma
business
Klatskin Tumor
Signal Transduction
Research Article
Zdroj: BMC Cancer
BMC cancer, 15(1). BioMed Central
ISSN: 1471-2407
Popis: Background Photodynamic therapy (PDT) of solid cancers comprises the administration of a photosensitizer followed by illumination of the photosensitizer-replete tumor with laser light. This induces a state of local oxidative stress, culminating in the destruction of tumor tissue and microvasculature and induction of an anti-tumor immune response. However, some tumor types, including perihilar cholangiocarcinoma, are relatively refractory to PDT, which may be attributable to the activation of survival pathways in tumor cells following PDT (i.e., activator protein 1 (AP-1)-, nuclear factor of kappa light polypeptide gene enhancer in B-cells (NF-κB)-, hypoxia-inducible factor 1-alpha (HIF-1α)-, nuclear factor (erythroid-derived 2)-like 2 (NFE2L2)-, and unfolded protein response-mediated pathways). Methods To assess the activation of survival pathways after PDT, human perihilar cholangiocarcinoma (SK-ChA-1) cells were subjected to PDT with zinc phthalocyanine (ZnPC)-encapsulating liposomes. Following 30-minute incubation with liposomes, the cells were either left untreated or treated at low (50 mW) or high (500 mW) laser power (cumulative light dose of 15 J/cm2). Cells were harvested 90 min post-PDT and whole genome expression analysis was performed using Illumina HumanHT-12 v4 expression beadchips. The data were interpreted in the context of the survival pathways. In addition, the safety of ZnPC-encapsulating liposomes was tested both in vitro and in vivo. Results PDT-treated SK-ChA-1 cells exhibited activation of the hypoxia-induced stress response via HIF-1α and initiation of the pro-inflammatory response via NF-кB. PDT at low laser power in particular caused extensive survival signaling, as evidenced by the significant upregulation of HIF-1- (P
Databáze: OpenAIRE